Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Xuefei Liu

机构:Nanchang University, Second Military Medical University, Inner Mongolia University, Southern University of Science and Technology, First Affiliated Hospital of Jiangxi Medical College, Jinshan Hospital of Fudan University, Second Affiliated Hospital of Nanchang University, Changhai Hospital, Shenzhen Children's Hospital · ORCID:0000-0002-1843-6107

发表论文 304 篇 · 总被引 5644 次 · h-index 35

代表论文

  • Data from NMB<sup>+</sup>CXCL13<sup>+</sup>CD4<sup>+</sup> T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy (2026)
  • Supplementary Table S7 from NMB<sup>+</sup>CXCL13<sup>+</sup>CD4<sup>+</sup> T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy (2026)
  • Supplementary Figure S11 from NMB<sup>+</sup>CXCL13<sup>+</sup>CD4<sup>+</sup> T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy (2026)
  • Supplementary Figure S5 from NMB<sup>+</sup>CXCL13<sup>+</sup>CD4<sup>+</sup> T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy (2026)
  • Supplementary Figure S10 from NMB<sup>+</sup>CXCL13<sup>+</sup>CD4<sup>+</sup> T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy (2026)
  • Supplementary Table S6 from NMB<sup>+</sup>CXCL13<sup>+</sup>CD4<sup>+</sup> T Cell–Derived Neuromedin B Promotes Neuropeptide S Receptor 1–Positive Malignant Cell Senescence and Malignancy (2026)